The leveraged buyouts that built an asset class, and the contested bids that produced the takeover case law still governing boards today.
28 deals
What is on this page. Public transaction history — announced values, deal structures, defensive tactics and outcomes, each with its source and year. Everything here is drawn from the public record. El Dorado Capital's own segment analysis, buyer universes and live deal work are maintained privately and are not published.
Landmark Leveraged Buyouts
RJR Nabisco / KKR (1988)
Value: ~$25 billion purchase price ($109/share final bid), closed February 1989 (Burrough & Helyar, Barbarians at the Gate, 1990; contemporary NYT/WSJ coverage, 1988-89).
Structure: KKR's winning bid emerged from a board-run auction against a management group (CEO Ross Johnson, backed by Shearson Lehman Hutton). Financed almost entirely with bank debt and Drexel Burnham junk bonds; KKR's equity check was a small fraction of total consideration, making RJR briefly the most indebted company in America.
The defence, if any: None in the anti-takeover sense — the special committee ran a competitive auction process rather than resisting a bid, itself a governance precedent for conflicted management buyouts.
Outcome: Closed, but the company was overleveraged; KKR's eventual exit through the 1990s is widely described in retrospectives (WSJ/NYT 20th-anniversary pieces, 2008) as roughly break-even rather than profitable.
Why it's in the encyclopedia: The apex and cautionary emblem of the 1980s LBO boom; established the mega-buyout auction playbook still used today.
Gibson Greeting Cards / Wesray Capital (1982)
Value: Purchased from RCA for roughly $80 million; taken public about 16 months later at a valuation near $290 million (contemporary press retrospectives; populisttalkpopulistmessage.substack.com, 2023, citing period reporting).
Structure: William Simon and Ray Chambers (Wesray Capital) put in roughly $1 million of their own equity against seller financing and bank debt — an extreme bootstrap.
The defence, if any: None — a friendly corporate divestiture by RCA.
Outcome: Hugely profitable for Wesray on a minimal equity outlay; no distress.
Why it's in the encyclopedia: Widely credited as the small deal that turned Wall Street's attention to the leveraged buyout as an asset class, kicking off the 1980s LBO boom that produced Beatrice, Safeway and ultimately RJR Nabisco.
Beatrice Companies / KKR (1985)
Value: Agreed at approximately $6.2 billion in November 1985 (Washington Post, 1985), total transaction value including assumed debt cited up to roughly $8.7 billion in later retrospectives.
Structure: Heavy junk-bond and bank-debt financing (Drexel Burnham); KKR equity was a minority share of consideration; the deal beat out a rival buyout attempt led by Beatrice's own management.
The defence, if any: None — a negotiated sale, not a contested takeover.
Outcome: KKR broke Beatrice into pieces over the following years, selling off dozens of operating units; profitable for KKR through asset sales, though Beatrice ceased to exist as a combined company.
Why it's in the encyclopedia: The largest LBO in history until RJR Nabisco surpassed it in 1988; established the "bust-up" LBO template of dismantling conglomerates for parts value.
Safeway / KKR (1986)
Value: Leveraged buyout valued at roughly $4.2-5.5 billion depending on measure (contemporary 1986 press; History of Private Equity and Venture Capital, Wikipedia).
Structure: KKR-backed leveraged recapitalization of Safeway's own board and management, financed with heavy debt subsequently paid down through large-scale store divestitures and closures.
The defence, if any: The LBO itself functioned as the defense — a friendly, debt-financed self-buyout undertaken to preempt a hostile approach from Herbert and Robert Haft's Dart Group.
Outcome: Successful long term — Safeway re-IPO'd in 1990 and became one of KKR's most profitable 1980s deals, though the debt-driven restructuring caused major layoffs and store closures, later chronicled critically in the documentary Store Wars.
Why it's in the encyclopedia: A textbook case of the "leveraged buyout as takeover defense," a precedent for debt-financed self-help recapitalizations used to defeat raiders.
Hospital Corporation of America (1988 & 2006)
Value: 1988 management buyout, led by founder Thomas Frist Jr., valued at approximately $5.1 billion. 2006 buyout by KKR, Bain Capital, Merrill Lynch Global Private Equity and the Frist family valued at approximately $33 billion — the largest LBO in history at signing (NPR, 2006; Nashville Post, 2006).
Structure: 2006 deal financed with roughly $25+ billion of debt against a multi-billion-dollar sponsor/family equity contribution, then the largest debt package assembled for an LBO.
The defence, if any: None — both were negotiated, board-approved transactions.
Outcome: The 2006 buyout is regarded as one of the most successful mega-LBOs of its vintage: HCA returned to public markets via a 2011 IPO, delivering a strong multiple return to sponsors (HBS case "HCA, Inc. LBO Exit"; NYT, 2011) despite closing just before the financial crisis.
Why it's in the encyclopedia: The same company bookends the two great American LBO waves, and the 2006 deal is the rare pre-crisis mega-buyout that thrived rather than collapsed.
Toys "R" Us / KKR-Bain Capital-Vornado (2005)
Value: $6.6 billion, announced March 2005.
Structure: KKR and Bain Capital acquired the operating business while Vornado Realty Trust took a real-estate joint-venture stake; the deal loaded roughly $5 billion of debt onto the retailer.
The defence, if any: None — a negotiated sale following a competitive process.
Outcome: Filed Chapter 11 in September 2017 and liquidated its US operations in 2018, eliminating roughly 30,000 jobs; the sponsors' equity investment of about $1.3 billion was wiped out (Forbes, 2017).
Why it's in the encyclopedia: The defining cautionary tale of private-equity overleveraging destroying a retailer; triggered 2019 congressional hearings and creditor litigation against KKR, Bain and Vornado executives.
Kinder Morgan (2006)
Value: Initial offer of approximately $13.5 billion in equity value (Forbes, May 2006), raised to roughly $15 billion equity / ~$22 billion total transaction value including assumed debt by the 2007 close.
Structure: Management-led buyout: CEO Richard Kinder, Goldman Sachs Capital Partners, AIG, Carlyle Group and Riverstone Holdings, with Kinder and management rolling significant equity.
The defence, if any: None — a negotiated MBO, though it drew shareholder litigation over conflicts of interest (In re Kinder Morgan, Inc. S'holders Litig.).
Outcome: Successful — Kinder Morgan relisted via a large 2011 IPO, delivering strong sponsor returns.
Why it's in the encyclopedia: One of the largest management-led buyouts ever, and a leading case on MBO conflict-of-interest process; a rare energy-infrastructure mega-buyout that succeeded cleanly.
Equity Office Properties / Blackstone (2006/07)
Value: Approximately $39 billion including assumed debt, closed February 2007 at $55.50/share after Vornado Realty Trust forced a bidding war.
Structure: Debt-financed acquisition of the largest US office-REIT portfolio, with Blackstone's strategy built around immediately reselling large portions of the portfolio.
The defence, if any: Not a defensive situation for the target; Vornado's competing bid is the notable feature, forcing Blackstone to raise its price.
Outcome: Blackstone rapidly flipped roughly two-thirds of the properties within months of closing, reportedly locking in a substantial profit just before the 2008 real-estate downturn — retrospectives (WSJ, Bloomberg) call it one of Blackstone's best-timed exits.
Why it's in the encyclopedia: The largest LBO in history at the moment it closed, and the case study in "buy, break up and sell" arbitrage executed at the top of a cycle.
TXU / Energy Future Holdings (2007)
Value: Approximately $45 billion including assumed debt, announced February 2007 — the largest LBO ever attempted.
Structure: KKR, TPG and Goldman Sachs Capital Partners contributed roughly $8 billion of equity against more than $40 billion of debt, betting that rising natural-gas prices would keep TXU's coal/nuclear generation fleet profitable.
The defence, if any: None — friendly, board-approved after a "go-shop" period.
Outcome: Natural-gas prices collapsed instead; Energy Future Holdings filed Chapter 11 in April 2014, wiping out essentially all of the sponsors' roughly $8 billion equity investment (Fortune, 2014; NPR, 2014).
Why it's in the encyclopedia: The largest LBO ever signed, and the single most-cited cautionary tale of pre-crisis mega-buyout excess and commodity-price hubris.
Hilton Hotels / Blackstone (2007)
Value: Approximately $26 billion including debt, announced July 2007 at $47.50/share, days before credit markets seized up.
Structure: Roughly $6.5 billion Blackstone equity against about $20 billion of acquisition debt.
The defence, if any: None — friendly deal.
Outcome: Hilton nearly breached debt covenants in 2008-09; Blackstone injected more capital and repurchased discounted Hilton debt, then IPO'd Hilton in December 2013 and fully exited by 2018 with a profit reported at roughly $14 billion — described by Blackstone and the Wall Street Journal (2018) as the most profitable private-equity deal ever.
Why it's in the encyclopedia: Turned from a near-disaster into private equity's most profitable buyout on record, illustrating both the risk and the upside of mega-LBO timing.
First Data / KKR (2007)
Value: Approximately $29 billion, announced April 2007 (CNBC, 2007).
Structure: KKR equity of roughly $5-6 billion against more than $24 billion of debt, one of the most heavily leveraged capital structures of the cycle.
The defence, if any: None — negotiated deal.
Outcome: First Data struggled under its debt load through the post-crisis payments slowdown; KKR held the company far longer than a typical hold, eventually exiting via a 2015 IPO and further sales before Fiserv acquired First Data in 2019. Reported returns were well below original underwriting case, though the company avoided bankruptcy.
Why it's in the encyclopedia: Represents the more common fate of 2006-07 vintage mega-LBOs — neither a blowout success nor an outright bankruptcy, but a long, debt-burdened survival.
Alliance Boots / KKR (2007)
Value: Approximately £11.1 billion (~$22 billion), announced April 2007 — Europe's largest LBO at the time.
Structure: KKR and Stefano Pessina financed the deal with heavy pre-crisis debt, later difficult to syndicate; sponsor equity was a minority share of consideration.
The defence, if any: None — negotiated deal, though the UK private-equity industry's tax and governance practices came under parliamentary scrutiny afterward.
Outcome: Successful exit — Walgreens acquired a 45% stake in 2012 for about $6.7 billion and completed a full merger in 2014 to form Walgreens Boots Alliance, delivering strong returns to KKR.
Why it's in the encyclopedia: The largest European LBO of the cycle and a rare 2007-vintage mega-deal that produced a clean, profitable strategic exit rather than distress.
Dell / Silver Lake, Michael Dell (2013)
Value: Approximately $24.4 billion ($13.65/share), announced February 2013.
Structure: Silver Lake contributed roughly $1.4 billion of equity, Michael Dell rolled his existing ~16% stake and personally lent the company $2 billion, with a $2 billion loan from Microsoft supplementing acquisition debt; Carl Icahn ran a proxy fight opposing the price before the deal closed.
The defence, if any: N/A (buyer-side take-private; Icahn's proxy contest was the friction, not a target defense against the buyer).
Outcome: After the 2016 EMC acquisition, funded partly with a VMware "Class V" tracking stock, Dell bought out the tracking stock for roughly $24 billion cash-and-stock in December 2018 and relisted on the NYSE, restoring public liquidity; both Michael Dell's stake and Silver Lake's investment appreciated substantially as Dell Technologies grew.
Why it's in the encyclopedia: The largest tech take-private of its era, and the VMware/EMC tracking-stock unwind is one of the most novel balance-sheet re-engineerings in M&A history.
Twitter / Elon Musk (2022)
Value: Approximately $44 billion ($54.20/share), agreed April 2022, closed October 2022.
Structure: About $13 billion in bank debt (led by Morgan Stanley) against roughly $27 billion of Musk and co-investor equity (including Sequoia, a16z and a rollover stake from Prince Alwaleed bin Talal).
The defence, if any: None from Twitter's board, which accepted the offer; Twitter instead had to sue in Delaware Chancery Court to force Musk to close after he tried to terminate, invoking the threat of specific performance.
Outcome: Renamed X; mutual funds including Fidelity marked their stakes down by more than half at points in 2023 before a 2025 merger with Musk's xAI restored/raised the disclosed valuation.
Why it's in the encyclopedia: The largest-ever take-private of a public tech/media company by an individual, and a landmark Delaware specific-performance case forcing a reluctant buyer to close.
Citrix Systems / Vista Equity Partners and Evergreen Coast Capital (2022)
Value: Approximately $16.5 billion, announced January 2022, closed September 2022, merged with TIBCO Software to form Cloud Software Group.
Structure: Roughly $15 billion of acquisition debt — one of the largest LBO debt packages assembled since the financial crisis — against several billion dollars of sponsor equity from Vista and Evergreen Coast Capital (Elliott Management's private-equity affiliate).
The defence, if any: None — negotiated deal.
Outcome: The debt was sold to banks and investors at a steep discount amid the 2022 rate-driven credit-market seizure, reportedly costing underwriting banks hundreds of millions of dollars; the underlying business subsequently stabilized.
Why it's in the encyclopedia: Effectively stress-tested the leveraged-loan market's reopening after the 2022 rate shock, and shows Elliott operating simultaneously as activist and buyout sponsor.
Landmark Hostile and Defensive Situations
Inco / ESB (1974)
Value: Reported figures vary by source (period accounts place it in the low hundreds of millions of dollars); a precise, consistently-cited headline number could not be confirmed.
Structure: International Nickel Company (Inco) launched a hostile cash tender offer directly to ESB Incorporated shareholders, bypassing ESB's board — advised by Goldman Sachs, one of the first "white-shoe" banks to work a hostile bid (SEC Historical Society oral history with Martin Lipton).
The defence, if any: ESB sought a white knight in Kennecott Copper, which agreed to a higher counter-offer.
Outcome: Inco prevailed after raising its bid and won control of ESB.
Why it's in the encyclopedia: Widely regarded as the deal that broke the postwar taboo against blue-chip companies and prestige investment banks pursuing hostile bids, making hostile takeovers a respectable strategic tool for the following decades.
Unocal Corp. / Mesa Petroleum (1985)
Value: Mesa Petroleum's two-tier hostile tender offer for Unocal was valued at approximately $8.1 billion.
Structure: Hostile tender offer; Unocal countered with a discriminatory self-tender offer, buying back its own shares at a premium while excluding Mesa, financed with new debt.
The defence, if any: The discriminatory self-tender/exclusionary offer, upheld by the Delaware Supreme Court in Unocal Corp. v. Mesa Petroleum Co., 493 A.2d 946 (Del. 1985).
Outcome: Mesa's bid was defeated; Unocal remained independent (acquired later, on friendly terms, by Chevron in 2005).
Why it's in the encyclopedia: Created the foundational "Unocal standard" — enhanced business-judgment review of defensive measures — one of the most cited corporate-law opinions in M&A history.
Household International / Moran (1985)
Value: Not applicable — this is a defensive-mechanism validation case, not a completed takeover.
Structure: N/A. Household International's board adopted the first modern shareholder rights plan ("poison pill") in 1984-85 without a pending bid.
The defence, if any: The poison pill itself — challenged by a dissident shareholder and upheld by the Delaware Supreme Court in Moran v. Household International, Inc., 500 A.2d 1346 (Del. 1985).
Outcome: The pill was upheld as a valid preventive defense under the business judgment rule; Household remained independent for nearly two decades (acquired on friendly terms by HSBC in 2003).
Why it's in the encyclopedia: Legalized the poison pill nationwide, making it the single most consequential takeover-defense mechanism in American corporate history.
Revlon / Pantry Pride (1985)
Value: Ronald Perelman's Pantry Pride raised its hostile tender offer from an initial $47.50/share to $58/share as the contest progressed.
Structure: Hostile tender offer; Revlon's board first adopted a poison pill and a debt-financed recapitalization, then sought white knight Forstmann Little, granting it a lock-up option on Revlon's most valuable divisions plus a no-shop clause.
The defence, if any: Poison pill, crown-jewel lock-up to a white knight, no-shop agreement — all enjoined/struck down.
Outcome: Pantry Pride won Revlon after the Delaware Supreme Court, in Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173 (Del. 1986), held the lock-up and no-shop impermissible once sale of the company had become inevitable.
Why it's in the encyclopedia: Created the "Revlon duties" doctrine — the board's obligation to maximize shareholder value once a sale is inevitable — one of the two or three most important Delaware M&A precedents.
Oracle / PeopleSoft (2003/04)
Value: Final agreed value approximately $10.3 billion (2004), after Oracle raised its unsolicited $18/share June 2003 offer to $26.50/share.
Structure: Hostile tender offer combined with a proxy fight to replace PeopleSoft's staggered board over successive annual meetings.
The defence, if any: PeopleSoft's staggered board and a "customer assurance program" (contractual refund guarantees to customers, triggering large liabilities if a hostile acquirer completed the deal); PeopleSoft also pushed the Department of Justice to sue on antitrust grounds (February 2004).
Outcome: Oracle won the federal antitrust trial (United States v. Oracle Corp., September 2004) and EU clearance, then completed the deal on negotiated terms in January 2005 after winning board seats via the proxy fight.
Why it's in the encyclopedia: A rare hostile acquirer that prevailed over both a customer-based poison-pill analogue and a full DOJ Section 7 antitrust trial — the leading precedent for hostile tech-sector deals surviving government challenge.
Sanofi / Aventis (2004)
Value: Initial hostile bid of approximately €47.8 billion (January 2004), raised to approximately €54.5 billion by the time terms were agreed (April 2004).
Structure: Hostile cash-and-share tender offer under French takeover rules.
The defence, if any: Aventis sought a white knight in Novartis; the French government publicly favored keeping Aventis under French control via Sanofi rather than a Swiss rescuer.
Outcome: Sanofi raised its offer and won board recommendation; deal completed August 2004, creating Sanofi-Aventis.
Why it's in the encyclopedia: A landmark case of government-influenced hostile M&A in Europe and one of the largest hostile pharmaceutical deals ever attempted.
Mittal Steel / Arcelor (2006)
Value: Initial unsolicited offer of approximately €18.6 billion (January 2006), rising to a final agreed value of roughly €26.9 billion (~$33 billion) by June 2006.
Structure: Hostile share-and-cash exchange offer opposed by Arcelor's board and by the French, Luxembourg and Belgian governments.
The defence, if any: Arcelor pursued a Pac-Man-style counter-defense by announcing a proposed merger with Russia's Severstal (a reverse "white knight" combination, May 2006) and raised nationalist political objections to a takeover by an India-founded, Netherlands-domiciled acquirer.
Outcome: Mittal prevailed after raising its offer and winning over Arcelor's board and largest shareholders, defeating the Severstal counter-bid; the deal closed in 2006, creating ArcelorMittal, the world's largest steelmaker.
Why it's in the encyclopedia: The largest hostile industrial takeover in European history to that point, testing whether "national champion" defenses could survive a determined, well-financed hostile bidder inside the EU single market.
Kraft Foods / Cadbury (2009/10)
Value: Initial hostile approach valued at approximately £10.2 billion (September 2009), raised to a final agreed value of approximately £11.9 billion (~$19.6 billion) in January 2010.
Structure: Cash-and-share hostile offer under the UK Takeover Code, resolved through direct shareholder acceptance rather than a US-style proxy fight.
The defence, if any: No poison pill is available under UK takeover law; Cadbury's board relied on public rejection of the price as "derisory" and searches for alternative bidders (Hershey and Ferrero were floated but never bid).
Outcome: Kraft won after raising its offer; deal completed February 2010. Kraft's subsequent 2012 split into Mondelez and a reversal of a factory-closure pledge triggered political controversy that led the UK Takeover Panel to tighten bid-timing and disclosure rules (2011).
Why it's in the encyclopedia: The deal that rewrote UK takeover regulation and remains the reference case for hostile bids in jurisdictions without US-style poison pills.
Air Products and Chemicals / Airgas (2010-11)
Value: Air Products' final unsolicited offer reached $70/share (February 2011), valuing Airgas at approximately $7.1-7.8 billion depending on measure; Airgas's board rejected it as inadequate.
Structure: Hostile tender offer combined with a multi-year proxy fight to replace one-third of Airgas's staggered board in successive annual elections.
The defence, if any: Airgas's staggered board plus a shareholder rights plan (poison pill), which Air Products sued to force redeemed.
Outcome: In a landmark February 2011 opinion, Delaware Chancery Court (Chancellor Chandler) upheld the pill even after Air Products had won board seats through the proxy fight, finding the board reasonably believed the price inadequate; Air Products abandoned its bid weeks later.
Why it's in the encyclopedia: The definitive precedent that a validly maintained poison pill plus a staggered board can indefinitely block a hostile bidder in Delaware — even one that has already won board representation — reshaping activist and hostile-bid strategy since.
Vodafone AirTouch / Mannesmann (1999-2000)
Value: Initial hostile all-share bid of roughly £80-90 billion (November 1999), with the final agreed deal valued at approximately $183 billion (~€190 billion) at closing in 2000.
Structure: Hostile exchange (share-for-share) tender offer taken directly to Mannesmann shareholders after the supervisory board rejected merger talks.
The defence, if any: Mannesmann's board explored alternative combinations and publicly resisted the "Anglo-Saxon" hostile approach as incompatible with German co-determination norms, but had no poison-pill-equivalent to block a direct shareholder tender.
Outcome: Vodafone won after raising its terms and persuading major shareholders, including Hutchison Whampoa; the deal closed in 2000.
Why it's in the encyclopedia: The largest hostile takeover in history by transaction value, and the deal that broke Germany's long-standing legal and cultural resistance to hostile takeovers.
Microsoft / Yahoo (2008, withdrawn)
Value: Approximately $44.6 billion ($31/share, a 62% premium), proposed February 2008.
Structure: Unsolicited bid with the threat of conversion into a formal tender offer and proxy fight to replace Yahoo's board; never actually converted before withdrawal.
The defence, if any: Yahoo's board rejected the price as inadequate, held a poison pill in reserve, and explored a search-advertising partnership with Google as an alternative (abandoned on antitrust concerns).
Outcome: Microsoft withdrew its offer in May 2008 after Yahoo continued holding out for a higher price (around $37/share); a narrower search-ad partnership followed in 2009 instead of an acquisition.
Why it's in the encyclopedia: A landmark failed hostile approach where a target's price discipline defeated a determined strategic bidder — but Yahoo's subsequent collapse in value made the episode a widely cited case of tactical defense success undermining long-run shareholder value.
Broadcom / Qualcomm (2017-18, blocked)
Value: Unsolicited bid raised to a final offer of approximately $117-121 billion ($82/share, February 2018), after Qualcomm's board rejected earlier approaches as inadequate.
Structure: Unsolicited bid combined with a full-slate proxy fight for Qualcomm's 2018 annual meeting, plus a plan to redomicile Broadcom from Singapore to the US to speed the deal's regulatory path.
The defence, if any: Regulatory referral — Qualcomm's national-security relevance in 5G standard-setting drew a Committee on Foreign Investment in the United States (CFIUS) review rather than a conventional poison pill.
Outcome: President Trump issued an executive order blocking the deal on national-security grounds in March 2018, days before Qualcomm's shareholder meeting.
Why it's in the encyclopedia: The definitive modern example of CFIUS/national-security review functioning as a hostile-takeover defense of last resort, and one of only a handful of instances of a US president blocking an M&A deal outright.
Elliott Management Activist Campaigns — Akzo Nobel (2017) and Arconic (2017)
Value: N/A — Elliott acted as an activist shareholder and litigant rather than a direct bidder in both situations; PPG Industries' unsolicited approach to Akzo Nobel was valued at approximately €26.3-28.4 billion.
Structure: Stake-building plus litigation and proxy-fight threats rather than a competing bid.
The defence, if any: At Akzo Nobel, the board relied on Dutch two-tier-board protections and a statutory "responstijd" (response-time) period to resist Elliott's demand to engage with PPG; at Arconic, Elliott ran a formal proxy contest.
Outcome: Akzo's board ultimately rejected PPG and instead merged its specialty-chemicals arm with Axalta (2017-18); at Arconic, CEO Klaus Kleinfeld was ousted before Elliott's nominees came to a vote.
Why it's in the encyclopedia: Illustrates activists using hostile-adjacent tactics — litigation, proxy threats, public pressure — to force value-realizing outcomes without making a bid themselves, now a distinct and recurring category alongside classic bidder-versus-target hostile situations.